Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease

Journal of Hepatology

Volumn 59, Issue 2, 2013, Pages 344-350

  Trépo, Eric ^a   Ouziel, Romy ^a   Pradat, Pierre ^b,c,d   Momozawa, Yukihide ^e   Quertinmont, Eric ^a   Gervy, Christine ^f   Gustot, Thierry ^a   Degré, Delphine ^a   Vercruysse, Vincent ^a   Deltenre, Pierre ^g   Verset, Laurine ^f   Gulbis, Beatrice ^f   Franchimont, Denis ^a   Devière, Jacques ^a   Lemmers, Arnaud ^a   Moreno, Christophe ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b CROIX ROUSSE HOSPITAL   (France)

^c INSERM   (France)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f ERASME HOSPITAL   (Belgium)

^g Hospital de Jolimont   (Belgium)

Author keywords

Alcoholic liver disease; Genetic factors; Inflammation; TNF ; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALCOHOL; ASPARTATE AMINOTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; VITAMIN D DEFICIENCY;

1,25(OH)(2)D; 1,25-DIHYDROXYVITAMIN D; 25(OH)D; 25-HYDROXYVITAMIN D; AC; AH; ALANINE AMINOTRANSFERASE; ALCOHOLIC CIRRHOSIS; ALCOHOLIC HEPATITIS; ALCOHOLIC LIVER DISEASE; ALD; ALT; ASPARTATE AMINOTRANSFERASE; AST; BMI; BODY MASS INDEX; CHC; CHRONIC HEPATITIS C; CI; CONA; CONCANAVALIN A; CONFIDENCE INTERVAL; CONTROL; CTRL; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHANOL; ETOH; GAMMA-GLUTAMYL TRANSFERASE; GENETIC FACTORS; GENOME-WIDE ASSOCIATION STUDIES; GGT; GWAS; HAZARDS RATIO; HCC; HEALTHY SUBJECTS; HEPATIC VENOUS PRESSURE GRADIENT; HEPATOCELLULAR CARCINOMA; HEPATORENAL SYNDROME; HPRT; HR; HRS; HS; HVPG; HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; INFLAMMATION; MELD; MODEL FOR END-STAGE LIVER DISEASE; NAFLD; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; OR; PBMCS; PERIPHERAL BLOOD MONONUCLEAR CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RT-PCR; SBP; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; SPONTANEOUS BACTERIAL PERITONITIS; TNFΑ; TUMOR NECROSIS FACTOR-Α; VITAMIN D;

ADULT; ANIMALS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84880282256     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.03.024     Document Type: Article

References (29)

1. J. Rehm, C. Mathers, S. Popova, M. Thavorncharoensap, Y. Teerawattananon, and J. Patra Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders Lancet 373 2009 2223 2233
2. European, Association for the Study of the Liver EASL clinical practical guidelines: management of alcoholic liver disease J Hepatol 57 2012 399 420
3. J. Rehm, B. Taylor, S. Mohapatra, H. Irving, D. Baliunas, and J. Patra Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis Drug Alcohol Rev 29 2010 437 445
4. S. Naveau, V. Giraud, E. Borotto, A. Aubert, F. Capron, and J.C. Chaput Excess weight risk factor for alcoholic liver disease Hepatology 25 1997 108 111
5. F. Stickel, S. Buch, K. Lau, H.M. Zu Schwabedissen, T. Berg, and M. Ridinger Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians Hepatology 53 2011 86 95
6. E. Trépo, T. Gustot, D. Degre, A. Lemmers, L. Verset, and P. Demetter Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease J Hepatol 55 2011 906 912
7. B. Gao, and R. Bataller Alcoholic liver disease: pathogenesis and new therapeutic targets Gastroenterology 141 2011 1572 1585
8. M.F. Holick Vitamin D deficiency N Engl J Med 357 2007 266 281
9. M.T. Kitson, and S.K. Roberts D-livering the message: the importance of vitamin D status in chronic liver disease J Hepatol 57 2012 897 909
10. G. Targher, L. Bertolini, L. Scala, M. Cigolini, L. Zenari, and G. Falezza Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease Nutr Metab Cardiovasc Dis 17 2007 517 524
11. S. Petta, C. Camma, C. Scazzone, C. Tripodo, V. Di Marco, and A. Bono Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Hepatology 51 2010 1158 1167
12. D. Bitetto, G. Fattovich, C. Fabris, E. Ceriani, E. Falleti, and E. Fornasiere Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C Hepatology 53 2011 1118 1126
13. C.M. Lange, J. Bojunga, E. Ramos-Lopez, M. von Wagner, A. Hassler, and J. Vermehren Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy J Hepatol 54 2011 887 893
14. S.C. Faria, K. Ganesan, I. Mwangi, M. Shiehmorteza, B. Viamonte, and S. Mazhar MR imaging of liver fibrosis: current state of the art Radiographics 29 2009 1615 1635
15. M.R. Lucey, P. Mathurin, and T.R. Morgan Alcoholic hepatitis N Engl J Med 360 2009 2758 2769
16. European, Association for the Study of the Liver, and European, Organisation for Research and Treatment of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
17. European, Association for the Study of the Liver EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis J Hepatol 53 2010 397 417
18. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
19. J. Bosch, J.G. Abraldes, A. Berzigotti, and J.C. Garcia-Pagan The clinical use of HVPG measurements in chronic liver disease Nat Rev Gastroenterol Hepatol 6 2009 573 582
20. M.R. McMullen, M.T. Pritchard, Q. Wang, C.A. Millward, C.M. Croniger, and L.E. Nagy Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice Gastroenterology 128 2005 2066 2076
21. H.A. Bischoff-Ferrari, E. Giovannucci, W.C. Willett, T. Dietrich, and B. Dawson-Hughes Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Am J Clin Nutr 84 2006 18 28
22. D.J. Balding A tutorial on statistical methods for population association studies Nat Rev Genet 7 2006 781 791
23. M. Malham, S.P. Jorgensen, P. Ott, J. Agnholt, H. Vilstrup, and M. Borre Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology World J Gastroenterol 17 2011 922 925
24. C.J. McClain, S.S. Barve, A. Barve, and L. Marsano Alcoholic liver disease and malnutrition Alcohol Clin Exp Res 35 2011 815 820
25. H. Tsukamoto, and S.C. Lu Current concepts in the pathogenesis of alcoholic liver injury FASEB J 15 2001 1335 1349
26. Y. Zhu, B.D. Mahon, M. Froicu, and M.T. Cantorna Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease Eur J Immunol 35 2005 217 224
27. J.M. Lemire Immunomodulatory role of 1,25-dihydroxyvitamin D3 J Cell Biochem 49 1992 26 31
28. K. Muller, P.M. Haahr, M. Diamant, K. Rieneck, A. Kharazmi, and K. Bendtzen 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level Cytokine 4 1992 506 512
29. C.L. Roth, C.T. Elfers, D.P. Figlewicz, S.J. Melhorn, G.J. Morton, and A. Hoofnagle Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation Hepatology 55 2012 1103 1111